Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina

{ 'indexed': {'date-parts': [[2022, 7, 11]], 'date-time': '2022-07-11T06:51:07Z', 'timestamp': 1657522267235}, 'reference-count': 18, 'publisher': 'Ovid Technologies (Wolters Kluwer Health)', 'issue': '5', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'DOI': '10.1097/mjt.0000000000001433', 'type': 'journal-article', 'created': {'date-parts': [[2021, 9, 2]], 'date-time': '2021-09-02T00:35:39Z', 'timestamp': 1630542939000}, 'page': 'e601-e604', 'source': 'Crossref', 'is-referenced-by-count': 5, 'title': 'Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for ' 'COVID-19 in Health Care Workers From Tucuman, Argentina', 'prefix': '10.1097', 'volume': '28', 'author': [ {'given': 'Rossana E.', 'family': 'Chahla', 'sequence': 'first', 'affiliation': []}, {'given': 'Luis', 'family': 'Medina Ruiz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eugenia S.', 'family': 'Ortega', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcelo F.', 'family': 'Morales, RN', 'sequence': 'additional', 'affiliation': []}, {'given': 'Francisco', 'family': 'Barreiro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexia', 'family': 'George', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cesar', 'family': 'Mancilla, RN', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sylvia', 'family': "D' Amato, RN", 'sequence': 'additional', 'affiliation': []}, {'given': 'Guillermo', 'family': 'Barrenechea', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel G.', 'family': 'Goroso', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Peral de Bruno', 'sequence': 'additional', 'affiliation': []}], 'member': '276', 'published-online': {'date-parts': [[2021, 9]]}, 'reference': [ { 'key': 'R1-20210907', 'doi-asserted-by': 'crossref', 'first-page': '645', 'DOI': '10.1038/448645a', 'article-title': 'New uses for old drugs', 'volume': '448', 'author': 'Chong', 'year': '2007', 'journal-title': 'Nature.'}, { 'key': 'R2-20210907', 'doi-asserted-by': 'crossref', 'first-page': '110', 'DOI': '10.1016/j.drudis.2012.08.005', 'article-title': 'In silico drug repositioning: what we need to know', 'volume': '18', 'author': 'Liu', 'year': '2013', 'journal-title': 'Drug Discov Today'}, { 'key': 'R3-20210907', 'doi-asserted-by': 'crossref', 'first-page': '673', 'DOI': '10.1038/nrd1468', 'article-title': 'Drug repositioning: identifying and developing new uses for existing ' 'drugs', 'volume': '3', 'author': 'Ashburn', 'year': '2004', 'journal-title': 'Nat Rev Drug Discov.'}, { 'key': 'R4-20210907', 'doi-asserted-by': 'crossref', 'first-page': '202', 'DOI': '10.1016/j.antiviral.2012.06.008', 'article-title': 'Nuclear trafficking of proteins from RNA viruses: potential target for ' 'antivirals?', 'volume': '95', 'author': 'Caly', 'year': '2012', 'journal-title': 'Antivir Res'}, { 'key': 'R5-20210907', 'doi-asserted-by': 'crossref', 'first-page': '104787', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'Since January 2020 Elsevier has created a COVID-19 resource centre with ' 'free information in English and Mandarin on the novel coronavirus ' 'COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect , ' "the company' s public news and information", 'volume': '178', 'author': 'Caly', 'year': '2020', 'journal-title': 'Antivir Res'}, { 'key': 'R6-20210907', 'doi-asserted-by': 'crossref', 'first-page': 'e299', 'DOI': '10.1097/MJT.0000000000001377', 'article-title': 'Review of the emerging evidence demonstrating the efficacy of ' 'ivermectin in the prophylaxis and treatment of COVID-19', 'volume': '28', 'author': 'Kory', 'year': '2021', 'journal-title': 'Am J Ther.'}, { 'key': 'R7-20210907', 'doi-asserted-by': 'crossref', 'first-page': '100720', 'DOI': '10.1016/j.eclinm.2020.100720', 'article-title': 'The effect of early treatment with ivermectin on viral load, symptoms ' 'and humoral response in patients with non-severe COVID-19: a pilot, ' 'double-blind, placebo-controlled, randomized clinical trial', 'volume': '3', 'author': 'Chaccour', 'year': '2021', 'journal-title': 'EClinicalMedicine.'}, { 'key': 'R8-20210907', 'doi-asserted-by': 'crossref', 'first-page': '100959', 'DOI': '10.1016/j.eclinm.2021.100959', 'article-title': 'Antiviral effect of high-dose ivermectin in adults with COVID-19: A ' 'proof-of-concept randomized trial', 'volume': '37', 'author': 'Krolewiecki', 'year': '2021', 'journal-title': 'EClinicalMedicine.'}, { 'key': 'R9-20210907', 'doi-asserted-by': 'crossref', 'first-page': '1007', 'DOI': '10.31546/2633-8653.1007', 'article-title': 'Study of the efficacy and safety of topical ivermectin + ' 'iota-carrageenan in the prophylaxis against COVID-19 in health ' 'personnel', 'volume': '2', 'author': 'Héctor', 'year': '2020', 'journal-title': 'J Biomed Res Clin Investig.'}, { 'key': 'R10-20210907', 'first-page': '1', 'article-title': 'Ivermectin as pre-exposure prophylaxis for COVID-19 among healthcare ' 'providers in a selected tertiary hospital in dhaka—an observational ' 'study', 'volume': '2', 'author': 'Alam', 'year': '2020', 'journal-title': 'Eur J Med Heal Sci.'}, { 'key': 'R11-20210907', 'first-page': '27', 'article-title': 'Use of ivermectin as a potential chemoprophylaxis for COVID-19 in ' 'Egypt: a randomized clinical trial', 'volume': '15', 'author': 'Shouman', 'year': '2021', 'journal-title': 'J Clin Diagn Res.'}, { 'key': 'R12-20210907', 'first-page': 'NCT047017', 'article-title': 'Prophylaxis covid-19 in health workers through intensive treatment with ' 'ivermectin and iota-carrageenan (Ivercar-Tuc)', 'volume': '20', 'author': 'Chahla', 'year': '2020', 'journal-title': 'ClinicalTrials.gov.'}, { 'key': 'R13-20210907', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s13063-020-04421-z', 'article-title': 'The sars-cov-2 ivermectin navarra-isglobal trial (saint) to evaluate ' 'the potential of ivermectin to reduce covid-19 transmission in low ' 'risk, non-severe covid-19 patients in the first 48 hours after symptoms ' 'onset: a structured summary of a study protocol', 'volume': '21', 'author': 'Chaccour', 'year': '2020', 'journal-title': 'Trials'}, { 'key': 'R14-20210907', 'first-page': '1', 'article-title': 'Covid 19 and ivermectin prevention and treatment update', 'volume': '4', 'author': 'Hirsch', 'year': '2020', 'journal-title': 'J Infect Dis Trav Med.'}, { 'key': 'R15-20210907', 'article-title': 'Clinical study evaluating the efficacy of ivermectin in COVID-19 ' 'treatment: A randomized controlled study [published online ahead of ' 'print, 2021 Jun 2]', 'author': 'Abd-Elsalam', 'year': '2021', 'journal-title': 'J Med Virol.'}, { 'key': 'R16-20210907', 'doi-asserted-by': 'crossref', 'first-page': '23', 'DOI': '10.1186/s12941-020-00368-w', 'article-title': 'Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19', 'volume': '19', 'author': 'Sharun', 'year': '2020', 'journal-title': 'Ann Clin Microbiol Antimicrob.'}, { 'key': 'R17-20210907', 'doi-asserted-by': 'crossref', 'first-page': '611', 'DOI': '10.3906/sag-2004-145', 'article-title': 'Antiviral treatment of covid-19', 'volume': '50', 'author': 'Şimşek Yavuz', 'year': '2020', 'journal-title': 'Turkish J Med Sci.'}, { 'key': 'R18-20210907', 'doi-asserted-by': 'crossref', 'first-page': 'e434', 'DOI': '10.1097/MJT.0000000000001402', 'article-title': 'Ivermectin for Prevention and Treatment of COVID-19 Infection: A ' 'Systematic Review, Meta-analysis, and Trial Sequential Analysis to ' 'Inform Clinical Guidelines', 'volume': '28', 'author': 'Bryant', 'year': '2021', 'journal-title': 'Am J Ther.'}], 'container-title': 'American Journal of Therapeutics', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://journals.lww.com/10.1097/MJT.0000000000001433', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 9, 7]], 'date-time': '2021-09-07T20:00:46Z', 'timestamp': 1631044846000}, 'score': 1, 'resource': {'primary': {'URL': 'https://journals.lww.com/10.1097/MJT.0000000000001433'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 8, 16]]}, 'references-count': 18, 'journal-issue': {'issue': '5', 'published-print': {'date-parts': [[2021]]}}, 'URL': 'http://dx.doi.org/10.1097/MJT.0000000000001433', 'relation': {}, 'ISSN': ['1075-2765'], 'subject': ['Pharmacology (medical)', 'Pharmacology', 'General Medicine'], 'published': {'date-parts': [[2021, 8, 16]]}}